Upgrade to SI Premium - Free Trial

UBS Reiterates Buy Rating on Cardinal Health (CAH)

March 27, 2026 9:25 AM
UBS analyst Kevin Caliendo reiterated a Buy rating and $260.00 price target on Cardinal Health (NYSE: CAH).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments